LifeStance Health Group (LFST)
(Delayed Data from NSDQ)
$5.23 USD
-0.14 (-2.61%)
Updated Sep 19, 2025 03:59 PM ET
After-Market: $5.22 -0.01 (-0.19%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
LFST 5.23 -0.14(-2.61%)
Will LFST be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LFST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LFST
LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates
Bet on 5 Top-Ranked Stocks With Rising P/E
LFST: What are Zacks experts saying now?
Zacks Private Portfolio Services
LifeStance Health (LFST) Upgraded to Strong Buy: What Does It Mean for the Stock?
After Plunging 9.9% in 4 Weeks, Here's Why the Trend Might Reverse for LifeStance Health (LFST)
Wall Street Analysts Think LifeStance Health (LFST) Could Surge 45.04%: Read This Before Placing a Bet
Other News for LFST
20 Day Moving Average Resistance appears for LFST after 2.61% move
LFST forms Stochastic Buy Signal on September 18
Lower Bollinger Band Walk appears for LFST after 1.53% move
TPG GP A, LLC Reduces Stake in Life Time Group Holdings Inc
Bullish Engulfing appears for LFST after 0.97% move